Importantly, several pathways dysregulated in AD were also upregulated in our dataset, including IL-5, IL-23, IL-17, and Jak-Stat signaling pathways (Figure 2B), noteworthy because many of these pathways are presently under clinical investigation for the treatment of AD (Paller et al., 2017). Here, SOAT1 is linked to Alzheimer disease.